GGrantIndex
Sort

48,018 grants matching immunotherapy

Cancer Stress Biology

$372,411
Elizabeth Repasky · Roswell Park Cancer Institute Corp · P30 · FY2025 · CA

Tumor Immunology and Immunotherapy

$372,408
Scott I. Abrams · Roswell Park Cancer Institute Corp · P30 · FY2025 · CA

Developmental Funds

$372,407
Candace S Johnson · Roswell Park Cancer Institute Corp · P30 · FY2025 · CA

Activation of Human Natural Killer Cell Function

$372,388
Eric O Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI

Understanding and countering mechanisms underlying IL-33-driven support of graft-vs. host disease

$372,382
Heth R. Turnquist · University Of Pittsburgh At Pittsburgh · R56 · FY2019 · AI

Development and Pre-Clinical Validation of Quantitative Imaging of Cell State Kinetics (QuICK) for Functional Precision Oncology

$372,336
Thomas Andrew Zangle · University Of Utah · R01 · FY2024 · CA

Role of cross-presentation by APCs in modulating graft-versus-leukemia responses

$372,336
Pavan Reddy · University Of Michigan At Ann Arbor · R01 · FY2009 · HL

Whole-brain Spectroscopy Guided Personalized Mapping of Transducer Arrays for Glioblastoma Patients Receiving Tumor Treating Fields

$372,319
Suyash Mohan · University Of Pennsylvania · R01 · FY2024 · CA

Reprogramming the Tumor Microenvironment in Pancreas Cancer to Enhance Immunotherapy

$372,237
Nipun B. Merchant · University Of Miami School Of Medicine · R01 · FY2019 · CA

Biostatistics Facility

$372,234
Daniel P. Normolle · University Of Pittsburgh At Pittsburgh · P30 · FY2021 · CA

Project 1: Targeting immunotherapy-induced resistance with DC vaccination and PD-1/CSF-1R inhibition

$372,200
Robert M Prins · University Of California Los Angeles · P50 · FY2022 · CA

DEVELOPMENT OF GENOMICS BASED PERSONALIZED CANCER IMMUNOTHERAPY

$372,200
Robert David Schreiber · Washington University · R01 · FY2019 · CA

PEPTIDE MEDIATED IMMUNOTHERAPY FOR AUTOIMMUNE DISEASE

$372,172
Stanford University · R01 · FY2000 · NS

Particulate-based in vivo modulation for immunotherapy of Rheumatoid Arthritis

$372,143
Jamal S Lewis · University Of California At Davis · R01 · FY2019 · AI

Multiplexed nanoparticle delivery to increase CRISPR/Cas gene editing for enhanced cancer therapy

$372,136
Daniel John Siegwart · Ut Southwestern Medical Center · R01 · FY2024 · CA

Credentialing a Genetically Engineered Clinically-Relevant Mouse Model of Multiple Myeloma

$372,131
Marta Chesi · Mayo Clinic Arizona · R01 · FY2022 · CA

Credentialing a Genetically Engineered Clinically-Relevant Mouse Model of Multiple Myeloma

$372,131
Marta Chesi · Mayo Clinic Arizona · R01 · FY2023 · CA

Molecular mechanisms of signaling co-ordination in innate lymphocytes

$372,108
Subramaniam Malarkannan · Medical College Of Wisconsin · R01 · FY2013 · AI

Role of cross-presentation by APCs in modulating graft-versus-leukemia responses

$372,106
Pavan Reddy · University Of Michigan At Ann Arbor · R01 · FY2010 · HL

Measuring and Programming Piconewton Receptor Forces for Synthetic Mechanobiology

$372,100
Joshua Mark Brockman · University Of Wisconsin-Madison · R35 · FY2025 · GM

Augmentation of Immune Response to Head & Neck Squamous Cell Carcinoma via Phosp

$372,068
Ivan M Borrello · Johns Hopkins University · P50 · FY2014 · DE

MOLECULAR CARCINOGENESIS IN THE MOUSE AND HUMAN PROSTATE

$372,066
Pier Paolo Pandolfi · Sloan-Kettering Inst Can Research · P50 · FY2007 · CA

Virulence and Immunity to Staphylcocci

$372,056
Brigham And Women'S Hospital · R01 · FY2005 · AI

Reprogramming the tumormicroenvironment to improve immunotherapy of glioblastoma

$372,041
Rakesh K. Jain · Massachusetts General Hospital · R01 · FY2023 · CA

UNIVERSITY OF COLORADO SOUTHWEST ONCOLOGY GROUP

$372,040
University Of Colorado Denver · U10 · FY2000 · CA